Subscribe to RSS
DOI: 10.1055/a-2760-7678
Shared Decision Making in Colorectal Cancer Screening
Authors
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related mortality in the United States, yet it is highly preventable through timely screening. This study reviews current CRC screening modalities—including colonoscopy, stool-based tests, flexible sigmoidoscopy, CT colonography, and capsule endoscopy—highlighting their respective strengths, limitations, and societal recommendations. It emphasizes the importance of tailoring screening strategies to individual patient risk profiles, including age, family history, comorbidities, and psychosocial factors. These screening modalities are discussed in the context of shared decision making, which is a critical strategy for primary care physicians, gastroenterologists, and colorectal surgeons to guide patients through screening choices, especially in underserved populations facing socioeconomic and cultural barriers.
Publication History
Article published online:
23 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin 2025; 75 (01) 10-45
- 2 Brenner H, Altenhofen L, Stock C, Hoffmeister M. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2013; 22 (06) 1043-1051
- 3 Chen C, Hoffmeister M, Brenner H. The toll of not screening for colorectal cancer. Expert Rev Gastroenterol Hepatol 2017; 11 (01) 1-3
- 4 Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?. Dig Dis Sci 2015; 60 (03) 681-691
- 5 Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011; 33 (01) 88-100
- 6 Montminy EM, Jang A, Conner M, Karlitz JJ. Screening for colorectal cancer. Med Clin North Am 2020; 104 (06) 1023-1036
- 7 Rex DK, Boland CR, Dominitz JA. et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol 2017; 112 (07) 1016-1030
- 8 Reumkens A, Rondagh EJA, Bakker CM, Winkens B, Masclee AAM, Sanduleanu S. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol 2016; 111 (08) 1092-1101
- 9 Schoen RE, Pinsky PF, Weissfeld JL. et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366 (25) 2345-2357
- 10 Zubarik R, Ganguly E, Benway D, Ferrentino N, Moses P, Vecchio J. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy. Am J Gastroenterol 2002; 97 (12) 3056-3061
- 11 Rex DK, Adler SN, Aisenberg J. et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 2015; 148 (05) 948-957.e2
- 12 Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014; 160 (03) 171-181
- 13 Kaur K, Zubair M, Adamski JJ. Fecal Occult Blood Test. StatPearls Publishing; 2023
- 14 Imperiale TF, Ransohoff DF, Itzkowitz SH. et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014; 370 (14) 1287-1297
- 15 Heigh RI, Yab TC, Taylor WR. et al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS One 2014; 9 (01) e85659
- 16 Song LL, Li YM. Current noninvasive tests for colorectal cancer screening: an overview of colorectal cancer screening tests. World J Gastrointest Oncol 2016; 8 (11) 793-800
- 17 Qaseem A, Harrod CS, Crandall CJ. et al; Clinical Guidelines Committee of the American College of Physicians. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians (version 2). Ann Intern Med 2023; 176 (08) 1092-1100
- 18 American Society of Colon and Rectal Surgeons Clinical Practice Guidelines Committee. Colorectal Cancer Screening and Surveillance Recommendations. Accessed July 20, 2025 at: https://fascrs.org/healthcare-providers/education/clinical-practice-guidelines/colorectal-cancer-screening-and-surveillance-recom
- 19 Wolf AMD, Fontham ETH, Church TR. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68 (04) 250-281
- 20 Davidson KW, Barry MJ, Mangione CM. et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2021; 325 (19) 1965-1977
- 21 Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 2021; 116 (03) 458-479
- 22 Patel SG, May FP, Anderson JC. et al. Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on colorectal cancer. Gastroenterology 2022; 162 (01) 285-299
- 23 Gupta S, Lieberman D, Anderson JC. et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2020; 158 (04) 1131-1153.e5
- 24 Hardiman KM, Felder SI, Friedman G, Migaly J, Paquette IM, Feingold DL. Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer. Dis Colon Rectum 2021; 64 (05) 517-533
- 25 Itzkowitz SH, Present DH. Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11 (03) 314-321
- 26 Ewing AP, Tounkara F, Marshall D. et al. Examining racial disparities in colorectal cancer screening and the role of online medical record use: findings from a cross-sectional study of a national survey. JMIR Cancer 2024; 10: e53229-e53229
- 27 Cancer TPR. Cancer Trends Progress Report National Cancer Institute,. NIH, DHHS, Bethesda, MD. April 2025 . Accessed July 24, 2025 at: https://progressreport.cancer.gov
- 28 Honein-AbouHaidar GN, Kastner M, Vuong V. et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2016; 25 (06) 907-917
- 29 Castañeda-Avila MA, Tisminetzky M, Oyinbo AG, Lapane K. Racial and ethnic disparities in use of colorectal cancer screening among adults with chronic medical conditions: BRFSS 2012-2020. Prev Chronic Dis 2024; 21: E12
- 30 Siegel RL, Miller KD, Goding Sauer A. et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020; 70 (03) 145-164
- 31 May FP, Yang L, Corona E, Glenn BA, Bastani R. Disparities in colorectal cancer screening in the United States before and after implementation of the Affordable Care Act. Clin Gastroenterol Hepatol 2020; 18 (08) 1796-1804.e2
- 32 Davis TC, Dolan NC, Ferreira MR. et al. The role of inadequate health literacy skills in colorectal cancer screening. Cancer Invest 2001; 19 (02) 193-200
- 33 Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med 2014; 46 (03) 228-236
- 34 Diaz JA, Roberts MB, Clarke JG, Simmons EM, Goldman RE, Rakowski W. Colorectal cancer screening: language is a greater barrier for Latino men than Latino women. J Immigr Minor Health 2013; 15 (03) 472-475
- 35 Jones RM, Woolf SH, Cunningham TD. et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med 2010; 38 (05) 499-507
- 36 Mota J, Almeida MJ, Martins M. et al. Artificial intelligence in coloproctology: a review of emerging technologies and clinical applications. J Clin Med 2024; 13 (19) 5842
- 37 Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial intelligence in colorectal cancer screening, diagnosis and treatment. A new era. Curr Oncol 2021; 28 (03) 1581-1607
- 38 Bai S, Singh B, Ethakota J. et al. Artificial intelligence in the diagnosis and management of colorectal cancer: a systematic review. Ann Med Clin Oncol 2025; 8 (01)
- 39 Ailawadi S, Kaelber DC, Elangovan A. Early-onset colorectal cancer: a review of current insights and a call for action. Biomedicines 2025; 13 (07) 1572
- 40 van den Puttelaar R, Meester RGS, Peterse EFP. et al. Risk-stratified screening for colorectal cancer using genetic and environmental risk factors: a cost-effectiveness analysis based on real-world data. Clin Gastroenterol Hepatol 2023; 21 (13) 3415-3423.e29
- 41 Corrales D, Ríos Insua D, González MJ. A decision support model for colorectal cancer screening. Comput Biol Med 2025; 196 (Pt B): 110755
- 42 Yogi TN, Bhusal A, Dulal S, Sharma R, Rauniyar K. Pioneering colorectal cancer screening: blood-based DNA tests as a global strategy for early detection - editorial. Int J Surg 2024; 110 (11) 6906-6910
- 43 Kamath SD, Torrejon N, Wei W. et al. Racial disparities negatively impact outcomes in early-onset colorectal cancer independent of socioeconomic status. Cancer Med 2021; 10 (21) 7542-7550
- 44 Muller C, Ihionkhan E, Stoffel EM, Kupfer SS. Disparities in early-onset colorectal cancer. Cells 2021; 10 (05) 1018
- 45 Park DK, Kim EJ, Im JP. et al. A prospective multicenter randomized controlled trial on artificial intelligence assisted colonoscopy for enhanced polyp detection. Sci Rep 2024; 14 (01) 25453
